Braves Predicted to Engineer Blockbuster Trade for $56M Cy Young Winner to Pair With Chris Sale in Rotation Shakeup
The Atlanta Braves have found themselves in a precarious position as spring training unfolds, with questions mounting around their starting pitching depth and overall rotation stability heading into the 2026 season.
Despite last season’s success and a roster that still features marquee names, one glaring concern has emerged: pitching health and consistency.
Atlanta entered camp brimming with optimism but soon received disappointing news on multiple fronts. Most notable was the injury to young right‑hander Spencer Schwellenbach, who has been placed on the 60‑day injured list with inflammation in his right elbow, prompting concerns of bone spurs that could sideline him for the early part of the season.
The hope within the organization was that Schwellenbach, after showing promise, would be an integral part of a rotation that already includes Chris Sale and Spencer Strider. Instead, that hope has been put on hold, placing even more emphasis on a rotation that now looks thinner than anticipated.
Atlanta’s depth concerns were compounded in early March when outfielder and designated hitter Jurickson Profar was suspended for 162 games after testing positive for a performance‑enhancing drug for the second time in his career.
The suspension, which will cost him the entire 2026 season and his $15 million salary, has freed up meaningful payroll flexibility — money the Braves could theoretically use in trade or free agency to bolster another area of need.
Profar’s absence leaves a hole in the lineup, but the more pressing long‑term question revolves around Atlanta’s starting pitching. The club enjoyed a strong rotation in recent years, but recent injuries have shown cracks in the depth chart that the front office now must address.
Why the Braves Are Looking for a Big Pitching Addition
In a season where the Braves are expected to compete in a stacked National League and push for postseason contention, questions linger about whether the current rotation can hold up over a grueling 162‑game schedule.
With rotation arms like Sale, Strider, and others still healthy, front office strategists are now looking for a true difference‑making starter — someone who can anchor the rotation behind those veterans and provide stability every fifth day.
That’s where the speculation around Sandy Alcantara enters the picture.
Alcantara, a former National League Cy Young Award winner (2022) and widely respected for his elite innings‑eating ability, has long been connected to trade speculation — especially with teams in need of starting pitching.
Listed on trade boards as one of the most intriguing possibilities at midseason, Alcantara represents exactly the kind of pitcher Atlanta could covet: a durable arm with a track record of dominating opposing lineups and handling high workloads.
Pairing such a veteran with Chris Sale — a pitcher known for his strikeout dominance when healthy — could create one of the most formidable top duos in all of baseball.
The Rotation of Dreams: Sale, Strider, Alcantara?
Imagine — if the Braves were to pull off a trade for Alcantara — a rotation that looks like this:
-
Chris Sale – the veteran ace with a history of brilliance (when on the mound)
-
Spencer Strider – the young flamethrower and strikeout machine
-
Sandy Alcantara – Cy Young pedigree and innings certainty
-
(Injured Schwellenbach when he returns)
-
Another back‑of‑rotation arm ready to step up
For Braves fans, that long list represents a possible core rotation with both high upside and veteran experience.
Such a rotation would not only be intimidating on paper but could give the Braves real leverage in a division where pitching depth will likely determine playoff positioning.
Bigger Picture: Braves in Win‑Now Mode
What’s been made clear from analysts and beat writers is that the Braves are expected to compete in 2026 — not rebuild.
A team with big names like Ronald Acuña Jr., Michael Harris II, Sale, and Strider does not typically enter a season with a rebuilding mindset. But external factors — injuries, suspensions, and depth issues — have forced Atlanta’s brass to reconsider how to maximize a championship window that still feels wide open.
Adding a veteran arm like Alcantara would signal a bold, aggressive approach by the front office — one that prioritizes long‑term competitiveness in the division and beyond.
It also would show that Atlanta is not afraid to deal with rivals — such as the Miami Marlins, Alcantara’s current team — to acquire the pieces necessary to remain at the top of the NL East hierarchy.
Financial Flexibility Following Profar Suspension
Profar’s suspension, while a blow, has created an unexpected silver lining for the Braves: payroll breathing room.
With his $15 million salary off the books for 2026 (and potentially the luxury tax burden reduced by about $3 million), Atlanta suddenly has more financial flexibility than it had two weeks ago.
That flexibility could be crucial if they decide to pursue a high‑value starter like Alcantara — whose contract and trade return would undeniably be significant.
It also opens the door to exploring free agent additions and bolstered bullpen arms if the Braves don’t land a major rotation piece via trade.
Pitching Depth Is Still Shaky
It’s not just Schwellenbach who’s been sidelined. Other young arms and rotation candidates are on questionable ground, leaving Atlanta thin outside of its established leaders.
Injuries to Hurston Waldrep earlier in spring training, combined with the loss of Profar’s offensive production, creates a sense of urgency to act before the season begins.
A rotation featuring just Chris Sale and Spencer Strider at the top — while formidable — could run into trouble if either suffers a midseason injury or fatigue.
That’s why the potential addition of a durable Cy Young winner like Alcantara becomes an even more enticing storyline as March turns to April.
Long‑Term Outlook: Competing vs. Rebuilding
This is the pivotal dilemma facing Braves fans and front office strategists:
Do they stay the course and let internal depth develop on the fly, or do they make a headline‑grabbing move to upgrade now?
Trading for Alcantara would be a statement — not just for 2026, but for the Braves’ short‑ and long‑term competitiveness in the National League.
And with the division as tightly contested as ever, every advantage matters.
Whether Atlanta pulls the trigger before Opening Day, waits until the trade deadline, or opts for alternative free agent signings, one thing is clear: whispers of a pitching blockbuster won’t be fading anytime soon.
